To determine the physiological significance of miR-20b targeting NFAT5 and CAMTA1, we assessed the expression levels of miR-20b, NFAT5, and CAMTA1 in thymoma tissue specimens from 30 thymoma-associated myasthenia gravis patients. The gene discussed is CAMTA1; the disease is thymoma.